Close Menu

NEW YORK – Agilent Technologies reported after the close of the market on Monday that its fiscal fourth quarter revenues rose 6 percent year over year, thanks largely to an 8 percent increase in revenues for its crosslab unit and a 5 percent increase in revenues in its diagnostics and genomics business.

For the three months ended Oct. 31, the firm said revenues rose to $1.37 billion from $1.29 billion in Q4 2018, beating the average Wall Street estimate of $1.33 billion. The company said core revenues grew 4 percent year over year in Q4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.